Logo
x

Search

Subscribe Now

Positive Opinion

Amgen's Lumykras (sotorasib) Receives CHMP's Positive Opinion for the Treatment of KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer

Amgen's Lumykras (sotorasib) Receives CHMP's Positive Opinion for the Treatment of KRAS G12C-Mutated Advanced Non-Small Cell Lung...

  • November 15, 2021
Celltrion's CT-P59 (regdanvimab) Receives CHMP's Positive Opinion for the Treatment of COVID-19

Celltrion's CT-P59 (regdanvimab) Receives CHMP's Positive Opinion for the Treatment of COVID-19

  • November 12, 2021
AbbVie-Skyrizi (risankizumab) Receives CHMP's Positive Opinion for the Treatment of Adults with Active Psoriatic Arthritis in the EU

AbbVie-Skyrizi (risankizumab) Receives CHMP's Positive Opinion for the Treatment of Adults with Active Psoriatic Arthritis in the...

  • October 18, 2021
Bristol Myers Squibb's Zeposia (ozanimod) Receives CHMP's Positive Opinion for Adult Patients with Moderately to Severely Active Ulcerative Colitis

Bristol Myers Squibb's Zeposia (ozanimod) Receives CHMP's Positive Opinion for Adult Patients with Moderately to Severely Active U...

  • October 15, 2021
Sanofi's Avalglucosidase alfa Receives CHMP's Positive Opinion for Patients with Pompe Disease

Sanofi's Avalglucosidase alfa Receives CHMP's Positive Opinion for Patients with Pompe Disease

  • July 28, 2021
Alexion's Ultomiris (ravulizumab) Receives CHMP's Positive Opinion Recommending its Approval for Children and Adolescents with PNH

Alexion's Ultomiris (ravulizumab) Receives CHMP's Positive Opinion Recommending its Approval for Children and Adolescents with PNH

  • July 26, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.